Most Recent
The Takeovers Panel has agreed to hear Mayne Pharma's latest dispute with Cosette over the US drug maker's attempts to walk away from their $672 million merger agreement and extended the timeline for completing the deal.
A judge has approved a "modest" $8.7 million settlement in a class action against medical device maker Exactech over allegedly defective joint replacements, saying the settlement was fair and reasonable given the limited assets of the company, whose parent has filed for bankruptcy in the US.
Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.
Cosette plans to appeal a ruling that rejected its bid to terminate an agreement to merge with Mayne Pharma, as the US drug company also refuses to agree to conditions needed to win Foreign Investment Review Board approval for the tie-up.
Mayne Pharma is not walking away from US drug maker Cosette's proposed takeover without a fight, filing an application with the Takeovers Panel to force Cosette to agree to the conditions needed to win FIRB approval for the $672 million deal.
A class action law firm is set to file a representative complaint against fertility services provider Genea over a data breach that led to sensitive patient information being published on the dark web.
Suspecting infringement of patents for its Parkinson's drug, Xadago, biopharmaceutical company Newron has won preliminary discovery of documents from generic drug maker Arrotex Pharmaceuticals.
Mayne Pharma is facing a new hurdle in its plans to merge with US drug maker Cosette, with the Treasurer flagging it may block the $672 million deal.
Nine has asked for more details of celebrity surgeon Dr Munjed Al Muderis' challenge to the dismissal of his defamation case against the broadcaster, and says 10 days is not enough to hear the appeal.
The federal government has flagged its intention to bring a strike-out application to narrow the group member definition in a class action by single women and same-sex couples who were denied Medicare rebates for IVF.